TABLE 2.
Types of cancer | Prostate | Gastric | Pancreatic | Cervical | Endometrial |
---|---|---|---|---|---|
(A) | |||||
References | Cheaito et al. 48 | Yan et al. 46 | Loomans et al. 47 | Lõhmussaar et al. 57 | Boretto et al. 144 |
Media composition | Advanced DMEM/F12 | Advanced DMEM / F12 | Advanced DMEM / F12 | Advanced DMEM / F12 | Advanced DMEM/F12 with L‐glutamine |
HEPES | HEPES | HEPES | HEPES | ||
Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | |
Glutamax | WNT3A | B27 | Glutamax | Glutamax | |
Gentamicin/Amphotericin B | R‐spondin 1 | EGF | B27 | B27 | |
Plasmocin | Noggin | N‐acetylcysteine | Nicotinamide | Nicotinamide | |
B27 | B27 | R‐spondin 1 | EGF | EGF | |
Nicotinamide | N‐acetylcysteine | Gastrin | FGF10 | bFGF | |
EGF | FGF10 | A83‐01 | FGF‐10 | ||
FGF2 | EGF | N‐acetylcysteine | A83‐01 | ||
FGF10 | Gastrin | Noggin | N‐acetylcysteine | ||
A83‐01 | A83‐01 | R‐spondin 1 | Noggin | ||
N‐acetylcysteine | Y‐27632 | p38 inhibitor | R‐spondin 1 | ||
Noggin | Y‐27632 | Insulin Transferrin Selenium | |||
R‐spondin 1 | FGF7 | Nitrogen | |||
p38 inhibitor | Forskolin | p38 inhibitor | |||
Dihydrotestosterone | CHIR | 17‐β Estradiol | |||
Y‐27632 | WNT surrogate | Y‐27632 | |||
17‐β Estradiol |
Types of cancer | Ovarian | Ovarian | Ovarian | Ovarian | Ovarian | Ovarian |
---|---|---|---|---|---|---|
(B) | ||||||
References | Hill et al. 49 | Kopper et al. 8 | Maru et al. 54 | Hoffmann et al. 52 | Maenhoudt et al. 145 | Nanki et al. 55 |
Wan et al. 9 | de Witte et al. 51 | |||||
Our group | ||||||
Media composition | Advanced DMEM/F12 | Advanced DMEM/F12 | Advanced DMEM/F12 | Advanced DMEM/F12 | Advanced DMEM/F12 | Advanced DMEM/F12 |
HEPES | HEPES | HEPES | HEPES | HEPES | HEPES | |
Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | Penicillin–Streptomycin | |
Glutamax | Glutamax | Glutamax | Glutamax | Glutamax | Glutamax | |
B27 | Primocin | EGF | B27 | B27 | B27 | |
Nicotinamide | B27 | Noggin | Nitrogen | Nitrogen | A83‐01 | |
EGF | Nicotinamide | R‐spondin 1 | Nicotinamide | Nicotinamide | N‐acetylcysteine | |
FGF2 | EGF | Y‐27632 | EGF | EGF | Noggin | |
FGF10 | FGF10 | p38 inhibitor | HGF | WNT3A | ||
A83‐01 | A83‐01 | Y‐27632 | A83‐01 | R‐spondin 1 | ||
N‐acetylcysteine | FGF10 | BMP2 | N‐acetylcysteine | Y‐27632 | ||
Noggin | A83‐01 | Noggin | IGF1 | |||
R‐spondin 1 | WNT3A | R‐spondin 1 | Leu15‐Gastrin I | |||
p38 inhibitor | R‐spondin 1 | p38 inhibitor | ||||
Hydrocortisone | 17‐β Estradiol | 17‐β Estradiol | ||||
Y‐27632 | Hydrocortisone | Y‐27632 | ||||
Y‐27632 | IGF1 | |||||
NRG1 |
Abbreviations: BMP2, bone morphogenetic protein 2; DMEM/12, Dulbecco's modified Eagle medium/nutrient mixture F12; ECF, epidermal growth factor; FGF2, fibroblast growth factor‐2; FGF10, fibroblast growth factor‐10; HGF, hepatocyte growth factor; HEPES, 4‐(2‐hydroxyethyl)‐1‐piperazine‐ethane‐sulfonic acid; IGF1, insulin‐like growth factor 1; NRG1, neuregulin‐1.